

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide biosynthetic process (GO:0009312) | 9.79095738 |
| 2 | pattern specification involved in kidney development (GO:0061004) | 7.46689561 |
| 3 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 6.98714168 |
| 4 | linoleic acid metabolic process (GO:0043651) | 6.64764013 |
| 5 | regulation of phospholipid biosynthetic process (GO:0071071) | 6.53624586 |
| 6 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 6.50460237 |
| 7 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 6.42021804 |
| 8 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 6.23226142 |
| 9 | acyl-CoA biosynthetic process (GO:0071616) | 6.21492203 |
| 10 | thioester biosynthetic process (GO:0035384) | 6.21492203 |
| 11 | phospholipid homeostasis (GO:0055091) | 6.13826506 |
| 12 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.13217259 |
| 13 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 6.11225069 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.75034201 |
| 15 | intestinal absorption (GO:0050892) | 5.60474063 |
| 16 | lactation (GO:0007595) | 5.49697355 |
| 17 | regulation of sequestering of triglyceride (GO:0010889) | 5.26487931 |
| 18 | regulation of penile erection (GO:0060405) | 5.25350460 |
| 19 | ceramide catabolic process (GO:0046514) | 5.10089171 |
| 20 | nucleoside transmembrane transport (GO:1901642) | 5.02481339 |
| 21 | biotin metabolic process (GO:0006768) | 5.01560391 |
| 22 | negative regulation of protein kinase B signaling (GO:0051898) | 5.00050524 |
| 23 | mammary gland epithelial cell differentiation (GO:0060644) | 4.95284054 |
| 24 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.87899472 |
| 25 | secretion by tissue (GO:0032941) | 4.83139968 |
| 26 | positive regulation of osteoblast proliferation (GO:0033690) | 4.80138660 |
| 27 | mitochondrial calcium ion transport (GO:0006851) | 4.77021847 |
| 28 | regulation of apoptotic cell clearance (GO:2000425) | 4.67616840 |
| 29 | carnitine shuttle (GO:0006853) | 4.63308155 |
| 30 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.60420768 |
| 31 | ectoderm development (GO:0007398) | 4.59095451 |
| 32 | nucleoside transport (GO:0015858) | 4.57618610 |
| 33 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.49338224 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 4.46776795 |
| 35 | positive regulation of p38MAPK cascade (GO:1900745) | 4.39647267 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 4.32766903 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 4.13402844 |
| 38 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.08720473 |
| 39 | nucleobase catabolic process (GO:0046113) | 4.06676022 |
| 40 | body fluid secretion (GO:0007589) | 4.04367198 |
| 41 | N-acetylneuraminate metabolic process (GO:0006054) | 3.99072818 |
| 42 | tricarboxylic acid metabolic process (GO:0072350) | 3.94667499 |
| 43 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.89386086 |
| 44 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 3.85209655 |
| 45 | glutathione biosynthetic process (GO:0006750) | 3.82254329 |
| 46 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.80414432 |
| 47 | response to host immune response (GO:0052572) | 3.73194792 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.73194792 |
| 49 | phagocytosis, recognition (GO:0006910) | 3.73055287 |
| 50 | tooth mineralization (GO:0034505) | 3.72599108 |
| 51 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.71132074 |
| 52 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.66995672 |
| 53 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.65375516 |
| 54 | intestinal cholesterol absorption (GO:0030299) | 3.60017400 |
| 55 | cellular carbohydrate biosynthetic process (GO:0034637) | 3.59902347 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.58618651 |
| 57 | triglyceride biosynthetic process (GO:0019432) | 3.56202034 |
| 58 | O-glycan processing (GO:0016266) | 3.52077435 |
| 59 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.50690849 |
| 60 | regulation of triglyceride metabolic process (GO:0090207) | 3.49550831 |
| 61 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.48277905 |
| 62 | acylglycerol biosynthetic process (GO:0046463) | 3.47098890 |
| 63 | neutral lipid biosynthetic process (GO:0046460) | 3.47098890 |
| 64 | response to phenylpropanoid (GO:0080184) | 3.45800018 |
| 65 | long-chain fatty acid transport (GO:0015909) | 3.42782562 |
| 66 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.41525922 |
| 67 | temperature homeostasis (GO:0001659) | 3.39527558 |
| 68 | exocrine pancreas development (GO:0031017) | 3.38667918 |
| 69 | copper ion transport (GO:0006825) | 3.37534259 |
| 70 | response to host (GO:0075136) | 3.36966598 |
| 71 | response to host defenses (GO:0052200) | 3.36966598 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36966598 |
| 73 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.36242118 |
| 74 | carnitine transmembrane transport (GO:1902603) | 3.35640696 |
| 75 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.31509140 |
| 76 | oligosaccharide metabolic process (GO:0009311) | 3.29303558 |
| 77 | regulation of fatty acid oxidation (GO:0046320) | 3.29119665 |
| 78 | folic acid transport (GO:0015884) | 3.26770179 |
| 79 | I-kappaB phosphorylation (GO:0007252) | 3.26028992 |
| 80 | positive regulation of macrophage cytokine production (GO:0060907) | 3.25771408 |
| 81 | regulation of execution phase of apoptosis (GO:1900117) | 3.24766507 |
| 82 | positive regulation of chemokine secretion (GO:0090197) | 3.24664160 |
| 83 | mitochondrion distribution (GO:0048311) | 3.23490472 |
| 84 | sialylation (GO:0097503) | 3.20279161 |
| 85 | lipid storage (GO:0019915) | 3.18276962 |
| 86 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.17588119 |
| 87 | coenzyme A biosynthetic process (GO:0015937) | 3.16491341 |
| 88 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.14181390 |
| 89 | cholesterol catabolic process (GO:0006707) | 3.12147955 |
| 90 | sterol catabolic process (GO:0016127) | 3.12147955 |
| 91 | segment specification (GO:0007379) | 3.11793510 |
| 92 | galactose metabolic process (GO:0006012) | 3.11524689 |
| 93 | fatty acid transport (GO:0015908) | 3.11502096 |
| 94 | regulation of heat generation (GO:0031650) | 3.10515018 |
| 95 | zinc ion transport (GO:0006829) | 3.09278304 |
| 96 | branched-chain amino acid metabolic process (GO:0009081) | 3.08851916 |
| 97 | carnitine transport (GO:0015879) | 3.04465119 |
| 98 | amino-acid betaine transport (GO:0015838) | 3.04465119 |
| 99 | sphingolipid catabolic process (GO:0030149) | 3.03157455 |
| 100 | branched-chain amino acid catabolic process (GO:0009083) | 3.01156429 |
| 101 | embryonic process involved in female pregnancy (GO:0060136) | 3.00563993 |
| 102 | regulation of lipid storage (GO:0010883) | 2.98303224 |
| 103 | regulation of cholesterol storage (GO:0010885) | 2.96832568 |
| 104 | purine nucleobase metabolic process (GO:0006144) | 2.96504219 |
| 105 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.96188757 |
| 106 | regulation of p38MAPK cascade (GO:1900744) | 2.93492249 |
| 107 | short-chain fatty acid metabolic process (GO:0046459) | 2.92273486 |
| 108 | regulation of fever generation (GO:0031620) | 2.92194802 |
| 109 | valine metabolic process (GO:0006573) | 2.91481123 |
| 110 | transcytosis (GO:0045056) | 2.90216340 |
| 111 | positive regulation of heat generation (GO:0031652) | 2.89294424 |
| 112 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.88979581 |
| 113 | proximal/distal pattern formation (GO:0009954) | 2.87783727 |
| 114 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.87095351 |
| 115 | steroid catabolic process (GO:0006706) | 2.86353354 |
| 116 | regulation of chemokine secretion (GO:0090196) | 2.85229245 |
| 117 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.78899712 |
| 118 | negative regulation of leukocyte migration (GO:0002686) | 2.76280316 |
| 119 | positive regulation of lipid storage (GO:0010884) | 2.75660700 |
| 120 | negative regulation of complement activation (GO:0045916) | 2.75472711 |
| 121 | response to histamine (GO:0034776) | 2.74548286 |
| 122 | behavioral response to cocaine (GO:0048148) | 2.71841906 |
| 123 | regulation of vasculogenesis (GO:2001212) | 2.71575930 |
| 124 | membrane lipid catabolic process (GO:0046466) | 2.71352997 |
| 125 | angiogenesis involved in wound healing (GO:0060055) | 2.70142392 |
| 126 | intracellular lipid transport (GO:0032365) | 2.68806525 |
| 127 | short-term memory (GO:0007614) | 2.67681992 |
| 128 | detection of external biotic stimulus (GO:0098581) | 2.67304957 |
| 129 | peptide biosynthetic process (GO:0043043) | 2.65251983 |
| 130 | COPI coating of Golgi vesicle (GO:0048205) | 2.64800016 |
| 131 | Golgi transport vesicle coating (GO:0048200) | 2.64800016 |
| 132 | regulation of macrophage cytokine production (GO:0010935) | 2.63257627 |
| 133 | regulation of endothelial cell differentiation (GO:0045601) | 2.61564414 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.60761069 |
| 135 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.60212946 |
| 136 | response to hydroperoxide (GO:0033194) | 2.59921766 |
| 137 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.58943223 |
| 138 | positive regulation of tissue remodeling (GO:0034105) | 2.57728033 |
| 139 | positive regulation of growth hormone secretion (GO:0060124) | 2.57579793 |
| 140 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.57441365 |
| 141 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.57441365 |
| 142 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.57441365 |
| 143 | early endosome to late endosome transport (GO:0045022) | 2.56600270 |
| 144 | negative regulation of protein activation cascade (GO:2000258) | 2.56460749 |
| 145 | protein O-linked glycosylation (GO:0006493) | 2.55324925 |
| 146 | fatty acid elongation (GO:0030497) | 2.53979958 |
| 147 | negative regulation of lipid catabolic process (GO:0050995) | 2.53216430 |
| 148 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.52940925 |
| 149 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.52916951 |
| 150 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.50917844 |
| 151 | muscle cell cellular homeostasis (GO:0046716) | 2.50852751 |
| 152 | negative regulation of cell fate commitment (GO:0010454) | 2.48836537 |
| 153 | acrosome assembly (GO:0001675) | 2.47747837 |
| 154 | ethanol oxidation (GO:0006069) | 2.45782172 |
| 155 | opsonization (GO:0008228) | 2.44715943 |
| 156 | regulation of acrosome reaction (GO:0060046) | 2.43972796 |
| 157 | coenzyme A metabolic process (GO:0015936) | 2.42292314 |
| 158 | digestive system process (GO:0022600) | 2.41203885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 4.98621484 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.10809921 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.34074845 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.12580678 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.97804433 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93337057 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.88026156 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.73844215 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.68646566 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.67787762 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.62371147 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50401932 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11981427 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.11034934 |
| 15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.11034934 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10483351 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06268417 |
| 18 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98482426 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.98374367 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.97319390 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95113744 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94189528 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.92507477 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86595760 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84777720 |
| 26 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.81896294 |
| 27 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70544649 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63559222 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63217176 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60386407 |
| 31 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.58779479 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58761550 |
| 33 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.56568799 |
| 34 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56214608 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51727688 |
| 36 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48787073 |
| 37 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47752477 |
| 38 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46950295 |
| 39 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44752406 |
| 40 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44508441 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44432021 |
| 42 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.42366305 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42130652 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38971694 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38568144 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37760320 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37523028 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37228660 |
| 49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36903846 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36575800 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36473071 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35461045 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35461045 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34507399 |
| 55 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32965564 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32158427 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31818781 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31445173 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.30722363 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.30722363 |
| 61 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30637046 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30380422 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26114312 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24299967 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23286842 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.22867655 |
| 67 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.22655641 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22617027 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22254761 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21861493 |
| 71 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21595247 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20946665 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20761610 |
| 74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20706046 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20660309 |
| 76 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.20058351 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19809403 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18621057 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18397284 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17929362 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15682189 |
| 82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15483186 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15437970 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14935021 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14579009 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13719835 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13519847 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13452508 |
| 89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12714931 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12018708 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11878429 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08642407 |
| 93 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08334099 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08101134 |
| 95 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07849963 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07804682 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07496142 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06369300 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06307532 |
| 100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06050678 |
| 101 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05723947 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05662494 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04684968 |
| 104 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04298685 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03955691 |
| 106 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03762663 |
| 107 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03193805 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03186607 |
| 109 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.03131305 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03104863 |
| 111 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.03081782 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02870648 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02461235 |
| 114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02286565 |
| 115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02250891 |
| 116 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02182133 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01889372 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99858960 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99707973 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99655708 |
| 121 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99528901 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98839053 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98357767 |
| 124 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97697072 |
| 125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96585353 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96133195 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95516900 |
| 128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.95159675 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94935522 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94691799 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94070497 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93919672 |
| 133 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92267528 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91962375 |
| 135 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91790323 |
| 136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91468220 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91301405 |
| 138 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91182527 |
| 139 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91002882 |
| 140 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90735649 |
| 141 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90247492 |
| 142 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.89689773 |
| 143 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89511718 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88902145 |
| 145 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88707519 |
| 146 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88544514 |
| 147 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88204665 |
| 148 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87976648 |
| 149 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.87853613 |
| 150 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87521367 |
| 151 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85467629 |
| 152 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82607684 |
| 153 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.80573355 |
| 154 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80137798 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79672692 |
| 156 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.79116516 |
| 157 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78096294 |
| 158 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77983094 |
| 159 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77011643 |
| 160 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75377758 |
| 161 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.74857774 |
| 162 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74747976 |
| 163 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74672052 |
| 164 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73669053 |
| 165 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72933888 |
| 166 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72803937 |
| 167 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.72330282 |
| 168 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.71998795 |
| 169 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.71878922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 5.81140846 |
| 2 | MP0005083_abnormal_biliary_tract | 4.36301717 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.21339477 |
| 4 | MP0003303_peritoneal_inflammation | 3.71793336 |
| 5 | MP0002254_reproductive_system_inflammat | 3.70963474 |
| 6 | MP0000627_abnormal_mammary_gland | 3.25927137 |
| 7 | MP0001873_stomach_inflammation | 3.04536583 |
| 8 | MP0005171_absent_coat_pigmentation | 2.55150902 |
| 9 | MP0001664_abnormal_digestion | 2.29838526 |
| 10 | MP0004130_abnormal_muscle_cell | 2.23261842 |
| 11 | MP0004147_increased_porphyrin_level | 2.22528001 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.19728008 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.13171776 |
| 14 | MP0001881_abnormal_mammary_gland | 11.3121862 |
| 15 | MP0003718_maternal_effect | 1.98906507 |
| 16 | MP0005670_abnormal_white_adipose | 1.80623009 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 1.75906138 |
| 18 | MP0003011_delayed_dark_adaptation | 1.61964659 |
| 19 | MP0004043_abnormal_pH_regulation | 1.53800345 |
| 20 | MP0001663_abnormal_digestive_system | 1.44005559 |
| 21 | MP0002098_abnormal_vibrissa_morphology | 1.38768329 |
| 22 | MP0005410_abnormal_fertilization | 1.37609582 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.36665528 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.34349004 |
| 25 | MP0002796_impaired_skin_barrier | 1.30795702 |
| 26 | MP0008004_abnormal_stomach_pH | 1.29929990 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.21422646 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.16188135 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.12454708 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.10791206 |
| 31 | MP0005381_digestive/alimentary_phenotyp | 1.08841499 |
| 32 | MP0005395_other_phenotype | 1.08119467 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.07085418 |
| 34 | MP0003690_abnormal_glial_cell | 1.05068803 |
| 35 | MP0009384_cardiac_valve_regurgitation | 1.03330725 |
| 36 | MP0010386_abnormal_urinary_bladder | 1.03167684 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.02928194 |
| 38 | MP0001177_atelectasis | 0.99899690 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 0.95975634 |
| 40 | MP0004858_abnormal_nervous_system | 0.95356815 |
| 41 | MP0003787_abnormal_imprinting | 0.93257266 |
| 42 | MP0010678_abnormal_skin_adnexa | 0.92843252 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 0.92074545 |
| 44 | MP0001849_ear_inflammation | 0.91989153 |
| 45 | MP0005646_abnormal_pituitary_gland | 0.90134844 |
| 46 | MP0005647_abnormal_sex_gland | 0.89924368 |
| 47 | MP0005595_abnormal_vascular_smooth | 0.89668580 |
| 48 | MP0009764_decreased_sensitivity_to | 0.87699552 |
| 49 | MP0003936_abnormal_reproductive_system | 0.86303137 |
| 50 | MP0005360_urolithiasis | 0.85865356 |
| 51 | MP0005248_abnormal_Harderian_gland | 0.85706197 |
| 52 | MP0005666_abnormal_adipose_tissue | 0.83523322 |
| 53 | MP0005332_abnormal_amino_acid | 0.82658653 |
| 54 | MP0000377_abnormal_hair_follicle | 0.82190940 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 0.81463102 |
| 56 | MP0004272_abnormal_basement_membrane | 0.79807227 |
| 57 | MP0005365_abnormal_bile_salt | 0.79480367 |
| 58 | MP0003283_abnormal_digestive_organ | 0.78967327 |
| 59 | MP0003075_altered_response_to | 0.77093587 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 0.75113498 |
| 61 | MP0005334_abnormal_fat_pad | 0.74797821 |
| 62 | MP0003959_abnormal_lean_body | 0.72667225 |
| 63 | MP0008260_abnormal_autophagy | 0.72343906 |
| 64 | MP0009379_abnormal_foot_pigmentation | 0.72277847 |
| 65 | MP0001188_hyperpigmentation | 0.71210537 |
| 66 | MP0009643_abnormal_urine_homeostasis | 0.70896849 |
| 67 | MP0003880_abnormal_central_pattern | 0.69929750 |
| 68 | MP0003950_abnormal_plasma_membrane | 0.69904770 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 0.69649900 |
| 70 | MP0005385_cardiovascular_system_phenoty | 0.69649900 |
| 71 | MP0002971_abnormal_brown_adipose | 0.69499630 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.68280274 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.68081043 |
| 74 | MP0003868_abnormal_feces_composition | 0.67784096 |
| 75 | MP0000003_abnormal_adipose_tissue | 0.67635231 |
| 76 | MP0002736_abnormal_nociception_after | 0.64641493 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.63982353 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.62948711 |
| 79 | MP0003938_abnormal_ear_development | 0.62548578 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.62135749 |
| 81 | MP0005451_abnormal_body_composition | 0.62077200 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.61869917 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.61677746 |
| 84 | MP0003195_calcinosis | 0.61121687 |
| 85 | MP0001984_abnormal_olfaction | 0.60650803 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.60438918 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.59379505 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.57693775 |
| 89 | MP0002009_preneoplasia | 0.57508551 |
| 90 | MP0010329_abnormal_lipoprotein_level | 0.57376719 |
| 91 | MP0000613_abnormal_salivary_gland | 0.57216790 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56214893 |
| 93 | MP0000566_synostosis | 0.55976285 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.55912829 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.54738664 |
| 96 | MP0002282_abnormal_trachea_morphology | 0.54262482 |
| 97 | MP0000579_abnormal_nail_morphology | 0.54227721 |
| 98 | MP0005501_abnormal_skin_physiology | 0.54152911 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.53872107 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.53573852 |
| 101 | MP0005165_increased_susceptibility_to | 0.53465604 |
| 102 | MP0000470_abnormal_stomach_morphology | 0.53268052 |
| 103 | MP0002168_other_aberrant_phenotype | 0.53157957 |
| 104 | MP0001958_emphysema | 0.52191118 |
| 105 | MP0001501_abnormal_sleep_pattern | 0.51699190 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.50613401 |
| 107 | MP0000490_abnormal_crypts_of | 0.50581431 |
| 108 | MP0000467_abnormal_esophagus_morphology | 0.50376094 |
| 109 | MP0001727_abnormal_embryo_implantation | 0.49192214 |
| 110 | MP0002876_abnormal_thyroid_physiology | 0.48930523 |
| 111 | MP0003948_abnormal_gas_homeostasis | 0.47786679 |
| 112 | MP0003448_altered_tumor_morphology | 0.47730540 |
| 113 | MP0003045_fibrosis | 0.47612793 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.47210157 |
| 115 | MP0002970_abnormal_white_adipose | 0.46563498 |
| 116 | MP0005448_abnormal_energy_balance | 0.45018685 |
| 117 | MP0005535_abnormal_body_temperature | 0.44984495 |
| 118 | MP0003953_abnormal_hormone_level | 0.44793391 |
| 119 | MP0005452_abnormal_adipose_tissue | 0.43122191 |
| 120 | MP0000858_altered_metastatic_potential | 0.42932268 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.42510098 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.42437457 |
| 123 | MP0004924_abnormal_behavior | 0.42437457 |
| 124 | MP0000163_abnormal_cartilage_morphology | 0.42272676 |
| 125 | MP0004133_heterotaxia | 0.41899566 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.41641172 |
| 127 | MP0002078_abnormal_glucose_homeostasis | 0.41475533 |
| 128 | MP0001756_abnormal_urination | 0.41157776 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.38432444 |
| 130 | MP0009763_increased_sensitivity_to | 0.36645409 |
| 131 | MP0001542_abnormal_bone_strength | 0.36220157 |
| 132 | MP0000343_altered_response_to | 0.35967512 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.35702700 |
| 134 | MP0002972_abnormal_cardiac_muscle | 0.34568515 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.33644774 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.33332729 |
| 137 | MP0008770_decreased_survivor_rate | 0.32439257 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.32399273 |
| 139 | MP0002148_abnormal_hypersensitivity_rea | 0.31855319 |
| 140 | MP0000751_myopathy | 0.31491429 |
| 141 | MP0005023_abnormal_wound_healing | 0.30357638 |
| 142 | MP0008874_decreased_physiological_sensi | 0.29264230 |
| 143 | MP0000609_abnormal_liver_physiology | 0.28442358 |
| 144 | MP0009785_altered_susceptibility_to | 0.28358440 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.27864664 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.27860790 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.27560816 |
| 148 | MP0000749_muscle_degeneration | 0.26049970 |
| 149 | MP0005620_abnormal_muscle_contractility | 0.25581560 |
| 150 | MP0000371_diluted_coat_color | 0.22881534 |
| 151 | MP0000762_abnormal_tongue_morphology | 0.21130311 |
| 152 | MP0003646_muscle_fatigue | 0.21053372 |
| 153 | MP0003699_abnormal_female_reproductive | 0.20602027 |
| 154 | MP0008775_abnormal_heart_ventricle | 0.20129068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 6.43422888 |
| 2 | Tubulointerstitial nephritis (HP:0001970) | 6.34319976 |
| 3 | Decreased circulating renin level (HP:0003351) | 6.18145488 |
| 4 | Amelogenesis imperfecta (HP:0000705) | 5.27454314 |
| 5 | Abnormality of purine metabolism (HP:0004352) | 4.94942749 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.44669570 |
| 7 | Gout (HP:0001997) | 4.43132183 |
| 8 | Axonal loss (HP:0003447) | 4.39818444 |
| 9 | Abnormal auditory evoked potentials (HP:0006958) | 4.39145259 |
| 10 | Metaphyseal dysplasia (HP:0100255) | 4.23102604 |
| 11 | Nephrolithiasis (HP:0000787) | 3.99659486 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.99614545 |
| 13 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.88727281 |
| 14 | Hypokalemic alkalosis (HP:0001949) | 3.87260127 |
| 15 | Turricephaly (HP:0000262) | 3.83998786 |
| 16 | Hyperkalemia (HP:0002153) | 3.82745653 |
| 17 | Tubulointerstitial fibrosis (HP:0005576) | 3.80746538 |
| 18 | Aplasia of the phalanges of the hand (HP:0009802) | 3.74096817 |
| 19 | Aplasia involving bones of the extremities (HP:0009825) | 3.74096817 |
| 20 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.74096817 |
| 21 | Hydronephrosis (HP:0000126) | 3.70520303 |
| 22 | Stridor (HP:0010307) | 3.57132929 |
| 23 | Skin nodule (HP:0200036) | 3.50637477 |
| 24 | Ectropion (HP:0000656) | 3.50561706 |
| 25 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.30693627 |
| 26 | Protruding tongue (HP:0010808) | 3.30681652 |
| 27 | Epiphyseal dysplasia (HP:0002656) | 3.27787551 |
| 28 | Hyperaldosteronism (HP:0000859) | 3.27500788 |
| 29 | Epidermoid cyst (HP:0200040) | 3.26068075 |
| 30 | Chronic bronchitis (HP:0004469) | 3.24308708 |
| 31 | Myocardial infarction (HP:0001658) | 3.19993666 |
| 32 | Curly hair (HP:0002212) | 3.19371558 |
| 33 | Tubular atrophy (HP:0000092) | 3.13729367 |
| 34 | Abnormality of the dental pulp (HP:0006479) | 3.10311212 |
| 35 | Hypotension (HP:0002615) | 3.07694671 |
| 36 | Glomerulonephritis (HP:0000099) | 3.06843385 |
| 37 | Tubulointerstitial abnormality (HP:0001969) | 2.98846351 |
| 38 | Xanthomatosis (HP:0000991) | 2.98500897 |
| 39 | Abnormality of renal excretion (HP:0011036) | 2.93946706 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92771063 |
| 41 | Hypoplasia of the iris (HP:0007676) | 2.87027265 |
| 42 | Hyponatremia (HP:0002902) | 2.85017531 |
| 43 | Flat acetabular roof (HP:0003180) | 2.84975009 |
| 44 | Hypoplastic nipples (HP:0002557) | 2.81750704 |
| 45 | Thin bony cortex (HP:0002753) | 2.78641334 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.78117763 |
| 47 | Hyperglycinuria (HP:0003108) | 2.75396028 |
| 48 | Blue irides (HP:0000635) | 2.73479240 |
| 49 | Abnormality of renin-angiotensin system (HP:0000847) | 2.71126987 |
| 50 | Nausea (HP:0002018) | 2.71059438 |
| 51 | Abnormality of chloride homeostasis (HP:0011422) | 2.68475972 |
| 52 | Complement deficiency (HP:0004431) | 2.67317775 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.67034907 |
| 54 | Abnormal tarsal ossification (HP:0008369) | 2.66131625 |
| 55 | Subcapsular cataract (HP:0000523) | 2.65258600 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.63681892 |
| 57 | Abnormality of renal resorption (HP:0011038) | 2.58228363 |
| 58 | Pili torti (HP:0003777) | 2.57738181 |
| 59 | Back pain (HP:0003418) | 2.56090734 |
| 60 | Overgrowth (HP:0001548) | 2.56031836 |
| 61 | White forelock (HP:0002211) | 2.55230113 |
| 62 | Severe muscular hypotonia (HP:0006829) | 2.49939594 |
| 63 | Protuberant abdomen (HP:0001538) | 2.47710017 |
| 64 | Onycholysis (HP:0001806) | 2.46959300 |
| 65 | Nephritis (HP:0000123) | 2.44808989 |
| 66 | Delayed epiphyseal ossification (HP:0002663) | 2.41369585 |
| 67 | Hyperglycinemia (HP:0002154) | 2.41066306 |
| 68 | Premature skin wrinkling (HP:0100678) | 2.40432064 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.40076873 |
| 70 | Enlarged epiphyses (HP:0010580) | 2.39135592 |
| 71 | Symptomatic seizures (HP:0011145) | 2.36602186 |
| 72 | Premature loss of primary teeth (HP:0006323) | 2.35710333 |
| 73 | Cortical visual impairment (HP:0100704) | 2.35408925 |
| 74 | Abnormality of sodium homeostasis (HP:0010931) | 2.34351120 |
| 75 | Hypoplasia of dental enamel (HP:0006297) | 2.31658457 |
| 76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30423872 |
| 77 | Hypothermia (HP:0002045) | 2.24449225 |
| 78 | Rickets (HP:0002748) | 2.23246078 |
| 79 | Patchy hypopigmentation of hair (HP:0011365) | 2.21988106 |
| 80 | Hyperuricemia (HP:0002149) | 2.21219602 |
| 81 | Increased purine levels (HP:0004368) | 2.21219602 |
| 82 | Widely patent fontanelles and sutures (HP:0004492) | 2.19844164 |
| 83 | Glomerulosclerosis (HP:0000096) | 2.18847018 |
| 84 | Bell-shaped thorax (HP:0001591) | 2.15489296 |
| 85 | Intrahepatic cholestasis (HP:0001406) | 2.14931593 |
| 86 | Adrenal overactivity (HP:0002717) | 2.14600660 |
| 87 | Azoospermia (HP:0000027) | 2.10120752 |
| 88 | Metabolic acidosis (HP:0001942) | 2.10066802 |
| 89 | Hypercholesterolemia (HP:0003124) | 2.08305558 |
| 90 | Tetraparesis (HP:0002273) | 2.06325311 |
| 91 | Alkalosis (HP:0001948) | 2.04654422 |
| 92 | Optic nerve hypoplasia (HP:0000609) | 2.03925346 |
| 93 | Split foot (HP:0001839) | 2.02324159 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.02015985 |
| 95 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99866887 |
| 96 | Neurodegeneration (HP:0002180) | 1.99720071 |
| 97 | Loss of speech (HP:0002371) | 1.98959299 |
| 98 | Hyperparathyroidism (HP:0000843) | 1.98434781 |
| 99 | Ventricular fibrillation (HP:0001663) | 1.98407858 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97899205 |
| 101 | Abnormality of complement system (HP:0005339) | 1.97358207 |
| 102 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96166244 |
| 103 | Abnormality of glycine metabolism (HP:0010895) | 1.96166244 |
| 104 | Abnormality of the renal cortex (HP:0011035) | 1.95219510 |
| 105 | Syncope (HP:0001279) | 1.94883902 |
| 106 | Spastic tetraparesis (HP:0001285) | 1.94485030 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 1.93742623 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.93308410 |
| 109 | Exotropia (HP:0000577) | 1.93211497 |
| 110 | Abnormal epiphyseal ossification (HP:0010656) | 1.89854442 |
| 111 | Hypokalemia (HP:0002900) | 1.89760531 |
| 112 | Hypophosphatemia (HP:0002148) | 1.88450067 |
| 113 | Stomach cancer (HP:0012126) | 1.87386881 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.87242456 |
| 115 | Hydroxyprolinuria (HP:0003080) | 1.87242456 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.84706898 |
| 117 | Genu varum (HP:0002970) | 1.83790827 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.83218410 |
| 119 | Neonatal hypoglycemia (HP:0001998) | 1.81776068 |
| 120 | Cerebellar dysplasia (HP:0007033) | 1.81473464 |
| 121 | Gingival overgrowth (HP:0000212) | 1.81240358 |
| 122 | Clumsiness (HP:0002312) | 1.79669590 |
| 123 | Aortic aneurysm (HP:0004942) | 1.79271004 |
| 124 | Hyperphosphatemia (HP:0002905) | 1.79190878 |
| 125 | Increased number of teeth (HP:0011069) | 1.79136281 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.78151276 |
| 127 | Abnormality of vision evoked potentials (HP:0000649) | 1.77935007 |
| 128 | Morphological abnormality of the inner ear (HP:0011390) | 1.77862004 |
| 129 | Abnormality of the costochondral junction (HP:0000919) | 1.77205943 |
| 130 | Type II lissencephaly (HP:0007260) | 1.76648660 |
| 131 | Lymphangioma (HP:0100764) | 1.76639476 |
| 132 | Congenital glaucoma (HP:0001087) | 1.76250982 |
| 133 | Supernumerary nipples (HP:0002558) | 1.76055210 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75735859 |
| 135 | Hypohidrosis (HP:0000966) | 1.75456387 |
| 136 | Abnormality of dental color (HP:0011073) | 1.74928326 |
| 137 | Purpura (HP:0000979) | 1.74923861 |
| 138 | Sudden death (HP:0001699) | 1.74433008 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74411746 |
| 140 | Right ventricular cardiomyopathy (HP:0011663) | 1.73080045 |
| 141 | Abdominal distention (HP:0003270) | 1.71098688 |
| 142 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.70997388 |
| 143 | Ketosis (HP:0001946) | 1.70691836 |
| 144 | Bone cyst (HP:0012062) | 1.69693826 |
| 145 | Pancreatitis (HP:0001733) | 1.69485632 |
| 146 | Renal salt wasting (HP:0000127) | 1.68784077 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68560341 |
| 148 | Polar cataract (HP:0010696) | 1.67347739 |
| 149 | Abnormality of the periventricular white matter (HP:0002518) | 1.67177153 |
| 150 | Prolonged QT interval (HP:0001657) | 1.66096381 |
| 151 | Hepatosplenomegaly (HP:0001433) | 1.65895031 |
| 152 | Hypoglycemic seizures (HP:0002173) | 1.65874785 |
| 153 | Rimmed vacuoles (HP:0003805) | 1.65238493 |
| 154 | Thoracic kyphosis (HP:0002942) | 1.64531665 |
| 155 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.63939297 |
| 156 | Type I transferrin isoform profile (HP:0003642) | 1.63805966 |
| 157 | Retinal atrophy (HP:0001105) | 1.63716017 |
| 158 | Buphthalmos (HP:0000557) | 1.63576917 |
| 159 | Broad metatarsal (HP:0001783) | 1.61952349 |
| 160 | Mixed hearing impairment (HP:0000410) | 1.61595522 |
| 161 | Vascular calcification (HP:0004934) | 1.61229128 |
| 162 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61109283 |
| 163 | Rhabdomyolysis (HP:0003201) | 1.60902238 |
| 164 | Foot dorsiflexor weakness (HP:0009027) | 1.59656230 |
| 165 | Primary adrenal insufficiency (HP:0008207) | 1.59528186 |
| 166 | Abnormal glycosylation (HP:0012345) | 1.59412577 |
| 167 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59412577 |
| 168 | Optic neuritis (HP:0100653) | 1.58381622 |
| 169 | Retrobulbar optic neuritis (HP:0100654) | 1.58381622 |
| 170 | Orchitis (HP:0100796) | 1.56774931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.21093008 |
| 2 | SIK1 | 4.40081909 |
| 3 | NTRK3 | 4.36024266 |
| 4 | CAMK1D | 3.70079632 |
| 5 | PKN2 | 3.14649059 |
| 6 | CAMK1G | 2.82231143 |
| 7 | ARAF | 2.23552580 |
| 8 | PIK3CG | 2.20810416 |
| 9 | TRIB3 | 2.17439553 |
| 10 | TESK1 | 2.09356223 |
| 11 | LATS1 | 2.09298399 |
| 12 | EEF2K | 2.05970407 |
| 13 | MAP3K6 | 2.03929189 |
| 14 | IRAK3 | 2.02877372 |
| 15 | EPHA4 | 2.00813225 |
| 16 | BCKDK | 1.98709163 |
| 17 | MAP3K14 | 1.95233705 |
| 18 | NLK | 1.87680130 |
| 19 | JAK3 | 1.71955394 |
| 20 | MAPK13 | 1.67321703 |
| 21 | LMTK2 | 1.62330567 |
| 22 | MAP3K7 | 1.47663889 |
| 23 | PTK6 | 1.44699725 |
| 24 | PDK4 | 1.43119736 |
| 25 | PDK3 | 1.43119736 |
| 26 | STK38L | 1.40425472 |
| 27 | ERN1 | 1.36019936 |
| 28 | TRPM7 | 1.33546522 |
| 29 | EPHA3 | 1.31070586 |
| 30 | PDK2 | 1.30725270 |
| 31 | STK38 | 1.30035338 |
| 32 | LRRK2 | 1.24972039 |
| 33 | MAP3K13 | 1.24771404 |
| 34 | PRPF4B | 1.22747894 |
| 35 | PIK3CA | 1.21401633 |
| 36 | MUSK | 1.21023370 |
| 37 | ICK | 1.19260887 |
| 38 | PINK1 | 1.17369202 |
| 39 | KSR2 | 1.15635494 |
| 40 | DAPK2 | 1.14818317 |
| 41 | MAP3K9 | 1.14337315 |
| 42 | EIF2AK2 | 1.14188940 |
| 43 | PDGFRB | 1.14119759 |
| 44 | FGFR4 | 1.12722084 |
| 45 | MOS | 1.10221252 |
| 46 | DDR2 | 1.05621944 |
| 47 | PRKAA2 | 1.04628570 |
| 48 | STK39 | 1.04511966 |
| 49 | MTOR | 1.04202735 |
| 50 | NME2 | 1.02971511 |
| 51 | FER | 1.02172670 |
| 52 | ZAP70 | 0.96159381 |
| 53 | BRAF | 0.91107169 |
| 54 | TAOK2 | 0.89122412 |
| 55 | MAPKAPK3 | 0.88889556 |
| 56 | MAPK12 | 0.87789064 |
| 57 | LIMK1 | 0.86859319 |
| 58 | EPHB1 | 0.86593597 |
| 59 | EIF2AK3 | 0.85628830 |
| 60 | WNK4 | 0.83972481 |
| 61 | CAMK2D | 0.83397269 |
| 62 | MAP3K1 | 0.82852736 |
| 63 | CAMK1 | 0.80435890 |
| 64 | TTN | 0.79461571 |
| 65 | TAOK1 | 0.78156422 |
| 66 | CHUK | 0.77299094 |
| 67 | TBK1 | 0.77104457 |
| 68 | CASK | 0.76690771 |
| 69 | IRAK1 | 0.74461497 |
| 70 | SGK223 | 0.74453148 |
| 71 | SGK494 | 0.74453148 |
| 72 | PRKG2 | 0.70971404 |
| 73 | MAP2K7 | 0.70152677 |
| 74 | JAK1 | 0.69066233 |
| 75 | PDPK1 | 0.68634956 |
| 76 | TESK2 | 0.67255349 |
| 77 | PRKAA1 | 0.66540876 |
| 78 | DMPK | 0.66192893 |
| 79 | IKBKE | 0.65769054 |
| 80 | CSNK2A2 | 0.64431396 |
| 81 | WNK1 | 0.64347100 |
| 82 | BMPR2 | 0.62519833 |
| 83 | BMX | 0.61197409 |
| 84 | TGFBR2 | 0.58892798 |
| 85 | STK24 | 0.58009602 |
| 86 | SGK3 | 0.57203560 |
| 87 | CAMK2B | 0.56566648 |
| 88 | FRK | 0.55245871 |
| 89 | ZAK | 0.52613442 |
| 90 | FGFR3 | 0.52461512 |
| 91 | SCYL2 | 0.51754929 |
| 92 | ILK | 0.51502798 |
| 93 | NUAK1 | 0.51013757 |
| 94 | CAMKK1 | 0.50810590 |
| 95 | CSNK1A1L | 0.50693523 |
| 96 | RPS6KL1 | 0.50683038 |
| 97 | RPS6KC1 | 0.50683038 |
| 98 | PDK1 | 0.48946385 |
| 99 | RPS6KB1 | 0.48243673 |
| 100 | TYK2 | 0.47660850 |
| 101 | NEK9 | 0.47644544 |
| 102 | ERBB4 | 0.47354045 |
| 103 | CSNK1A1 | 0.46165595 |
| 104 | PRKCD | 0.45893151 |
| 105 | MAP2K2 | 0.44306467 |
| 106 | RET | 0.44258084 |
| 107 | INSRR | 0.43274919 |
| 108 | IRAK4 | 0.41827725 |
| 109 | MAPKAPK5 | 0.40987851 |
| 110 | RPS6KA6 | 0.40513161 |
| 111 | FES | 0.40259378 |
| 112 | PRKCE | 0.40028491 |
| 113 | MAP3K5 | 0.39899402 |
| 114 | STK3 | 0.39864616 |
| 115 | TIE1 | 0.38704238 |
| 116 | NEK6 | 0.38068111 |
| 117 | CDC42BPA | 0.37363554 |
| 118 | MARK3 | 0.36486790 |
| 119 | RIPK1 | 0.35821349 |
| 120 | IGF1R | 0.34798801 |
| 121 | GSK3A | 0.34202370 |
| 122 | MAPK11 | 0.33626299 |
| 123 | BTK | 0.33250114 |
| 124 | IRAK2 | 0.33059256 |
| 125 | GRK6 | 0.32853170 |
| 126 | PRKACG | 0.32089829 |
| 127 | JAK2 | 0.31663315 |
| 128 | FGR | 0.29840255 |
| 129 | RPS6KA2 | 0.29630781 |
| 130 | CSNK1G2 | 0.29084218 |
| 131 | CSNK1G1 | 0.28235535 |
| 132 | STK16 | 0.27284487 |
| 133 | PHKG2 | 0.26781714 |
| 134 | PHKG1 | 0.26781714 |
| 135 | PIM1 | 0.26737498 |
| 136 | NME1 | 0.25557292 |
| 137 | SGK2 | 0.25123173 |
| 138 | MYLK | 0.24869287 |
| 139 | PRKCG | 0.24509776 |
| 140 | PRKD1 | 0.23452397 |
| 141 | MAP2K6 | 0.22950842 |
| 142 | OBSCN | 0.21216831 |
| 143 | PTK2 | 0.21072362 |
| 144 | SGK1 | 0.20948611 |
| 145 | RPS6KB2 | 0.20350883 |
| 146 | CAMK2A | 0.19778171 |
| 147 | CAMK2G | 0.19728150 |
| 148 | CSNK1D | 0.19580909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 9.13437997 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 7.07222143 |
| 3 | Galactose metabolism_Homo sapiens_hsa00052 | 2.98701659 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.88908759 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.45258727 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.24675634 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.18469922 |
| 8 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 2.00768577 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.98683596 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.94377740 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.78691199 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70590768 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40333778 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35162071 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.34271713 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08267163 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06255080 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05694310 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03613921 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00747240 |
| 21 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97885826 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94398695 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89640784 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87859576 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83986502 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80179336 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79054802 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75937771 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73930315 |
| 30 | Protein export_Homo sapiens_hsa03060 | 0.73778891 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72350974 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 0.72087028 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71821531 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 0.71187657 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70803739 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66739875 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66598028 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64422508 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64024097 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62881268 |
| 41 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60385892 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59513633 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58951047 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58622573 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57865537 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 0.56576951 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52182730 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.49875254 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49380365 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48643307 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48192159 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47475381 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45324527 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44763343 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43702159 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43470137 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42954289 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42247623 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42201478 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41780517 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40848901 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40105661 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.39877077 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39810705 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38363049 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.37806972 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37664411 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37518430 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.37410730 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36614484 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35674485 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35408241 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33908615 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32952511 |
| 75 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32767327 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32598092 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.32362792 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30474323 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29446573 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.28106035 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27905411 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27529677 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.27456824 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27354630 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26598649 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.25580183 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.25219121 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25134448 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23573941 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22340524 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22076704 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21064205 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20988015 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20821244 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20442640 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20411665 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.19857085 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19649722 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.19044391 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.18676932 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18674526 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18062926 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18048391 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17877339 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17653283 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.17547142 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16952235 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16839487 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.16661999 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15313053 |
| 111 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14765416 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.14710947 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14301942 |
| 114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14290855 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13950095 |
| 116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.13539804 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.13495920 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13481699 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13383848 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.13244468 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.13083504 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12500980 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11481150 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.11446020 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10619532 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08901125 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.06490134 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.05566175 |
| 129 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.04915823 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.03072270 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.01579326 |
| 132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.01293247 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.00461279 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.00211775 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0542505 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0485521 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0426503 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0372056 |
| 139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0361226 |
| 140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0337963 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | -0.0310357 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | -0.0245410 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0107019 |
| 144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0079486 |
| 145 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0044638 |

